Comparison of four aortic bioprostheses: Hancock II vs. St Jude Trifecta vs. Carpentier-Edwards Perimount Magna vs. Magna Ease-mid-term results (COMPARE SAVR study).

Natalia BajorekGrzegorz FilipKrzysztof MalinowskiAnna KędzioraPiotr MazurKrithika RamaprabhuKrzysztof BartuśJakub BatkoDaniel J RamsMarek DejaKazimierz WidenkaZdzisław TobotaBohdan J MaruszewskiMarian BuryszRadoslaw Litwinowicz

Published in: Journal of thoracic disease (2024)

The 5-year mortality rate was significantly higher in the Hancock II group compared to the other bioprostheses. In contrast, Trifecta, Perimount Magna, and Magna Ease had similar 5-year mortality rates.

Keyphrases

cardiovascular events
aortic valve replacement
aortic valve
risk factors
magnetic resonance
pulmonary artery
heart failure
magnetic resonance imaging
computed tomography
cardiovascular disease
coronary artery disease
coronary artery
aortic stenosis